Darwin Private Equity, founded in 2007 by former executives from Permira and CVC, has made its first exit with the £162m sale of sports nutrition company Maxinutrition to GlaxoSmithKline.
This article is only available to subscribers to unquote.com. Subscribers just need to log in below for immediate access. Not a subscriber? Sign up now for immediate free trial access
Sign up
Free trial
Try unquote.com free for 2 weeks. A trial will give you access to the entire site.